CI 912

Known as: CI-912 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-1990
01219841990

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1990
1990
The effects of a novel anticonvulsant, zonisamide (3-sulfamoylmethyl-1,2-benzisoxazole), on photically induced seizures were… (More)
Is this relevant?
1987
1987
Nine patients with refractory partial seizures were evaluated in a pilot study of a new anticonvulsant compound, zonisamide (1,2… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
1987
1987
The effect of the experimental antiepileptic drug zonisamide (1,2-benzisoxazole-3-methanesulfonamide, ZNS) on the trigeminal… (More)
Is this relevant?
1987
1987
The effects of 1,2-benzisoxazole-3-methanesulfonamide (zonisamide, AD-810, CI-912), an antiepileptic compound, on the central… (More)
Is this relevant?
1987
1987
The effects of 1,2-benzisoxazole-3-methanesulfonamide (zonisamide, AD-810, CI-912), an antiepileptic compound, on the… (More)
Is this relevant?
1986
1986
Zonisamide (CI-912) is an experimental antiepileptic drug. Since this drug is to be evaluated initially as an add-on medication… (More)
Is this relevant?
1986
1986
Effects of zonisamide (AD-810, CI-912) were examined on tungstic acid gel-induced thalamic generalized seizures and conjugated… (More)
Is this relevant?
1985
1985
Brain capillary transit of CI-912 was studied in vivo after a single capillary transit by the intracarotid injection technique… (More)
Is this relevant?
1984
1984
We studied the pharmacokinetics of CI-912 (1,2-benziosoxazole-3-methanesulfonamide) in 10 adults with refractory partial seizures… (More)
Is this relevant?